Performance Improvement 2013-2014. What is the Cost-Effectiveness of Rectal Chlamydia/Gonorrhea Screening in Men Having Sex with Men with HIV Infection Prevention as the Primary Outcome?


This study determined the cost-effectiveness of rectal Chlamydia/Gonorrhea screening in men having sex with men on averting HIV infection. The study used a statistical model to estimate the cost and cases of HIV attributable to rectal chlamydia and gonorrhea that could be averted by screening men having sex with men.

Rectal screening was cost-saving. The impact of rectal chlamydia/gonorrhea infection on the risk of HIV acquisition was the most influential model parameter.

Report Title: Cost-Effectiveness of Rectal Chlamydia/Gonorrhea (CT/GC) Screening in Men Who Have Sex With Men (MSM)
Agency Sponsor: CDC, Centers for Disease Control and Prevention
Federal Contact: Thomas Chapel, 404-639-2116
Performer: DSTDP/HSREB
Record ID: 9588 (March 21, 2013)

View full report


"PerformanceImprovement2014.pdf" (pdf, 671.65Kb)

Note: Documents in PDF format require the Adobe Acrobat Reader®. If you experience problems with PDF documents, please download the latest version of the Reader®